Suppr超能文献

同步游离皮质醇评估可增强异常地塞米松抑制试验的解读。

Interpretation of Abnormal Dexamethasone Suppression Test is Enhanced With Use of Synchronous Free Cortisol Assessment.

机构信息

Division of Endocrinology, Metabolism, and Lipid Research, Washington University School of Medicine; Saint Louis, MO 63130, USA.

Division of Endocrinology, Diabetes, Metabolism and Nutrition, Mayo Clinic, Rochester, MN 55905, USA.

出版信息

J Clin Endocrinol Metab. 2022 Feb 17;107(3):e1221-e1230. doi: 10.1210/clinem/dgab724.

Abstract

CONTEXT

Interpretation of dexamethasone suppression test (DST) may be influenced by dexamethasone absorption and metabolism and by the altered cortisol binding.

OBJECTIVE

We aimed to determine the normal ranges of free cortisol during DST in participants without adrenal disorders and to identify the population of patients where post-DST free cortisol measurements add value to the diagnostic workup.

DESIGN AND SETTING

Cross-sectional study conducted in a tertiary medical center.

PARTICIPANTS

Adult volunteers without adrenal disorders (n = 168; 47 women on oral contraceptive therapy [OCP], 66 women not on OCP, 55 men) and patients undergoing evaluation for hypercortisolism (n = 196; 16 women on OCP).

MEASUREMENTS

Post-DST dexamethasone and free cortisol (mass spectrometry) and total cortisol (immunoassay).

MAIN OUTCOME MEASURES

Reference range for post-DST free cortisol, diagnostic accuracy of post-DST total cortisol.

RESULTS

Adequate dexamethasone concentrations (≥0.1 mcg/dL) were seen in 97.6% volunteers and 96.3% patients. Only 25.5% of women volunteers on OCP had abnormal post-DST total cortisol (>1.8 mcg/dL). In volunteers, the upper post-DST free cortisol range was 48 ng/dL in men and women not on OCP, and 79 ng/dL in women on OCP. When compared with post-DST free cortisol, diagnostic accuracy of post-DST total cortisol was 87.3% (95% CI, 81.7-91.7); all false-positive results occurred in patients with post-DST cortisol between 1.8 and 5 mcg/dL. OCP use was the only factor associated with false-positive results (21.1% vs 4.9%, P = 0.02).

CONCLUSIONS

Post-DST free cortisol measurements are valuable in patients with optimal dexamethasone concentrations and post-DST total cortisol between 1.8 and 5 mcg/dL.

摘要

背景

地塞米松抑制试验(DST)的解读可能受到地塞米松的吸收和代谢以及皮质醇结合的改变的影响。

目的

我们旨在确定无肾上腺疾病参与者 DST 期间游离皮质醇的正常范围,并确定 DST 后游离皮质醇测量对诊断评估有价值的患者人群。

设计和设置

在一家三级医疗中心进行的横断面研究。

参与者

无肾上腺疾病的成年志愿者(n=168;47 名口服避孕药治疗[OCP]的女性,66 名未服用 OCP 的女性,55 名男性)和接受高皮质醇血症评估的患者(n=196;16 名服用 OCP 的女性)。

测量

DST 后地塞米松和游离皮质醇(质谱法)和总皮质醇(免疫测定法)。

主要观察指标

DST 后游离皮质醇的参考范围,DST 后总皮质醇的诊断准确性。

结果

97.6%的志愿者和 96.3%的患者地塞米松浓度足够(≥0.1 mcg/dL)。仅 25.5%的服用 OCP 的女性志愿者 DST 后总皮质醇异常(>1.8 mcg/dL)。在志愿者中,未服用 OCP 的男性和女性志愿者的 DST 后游离皮质醇上限范围为 48 ng/dL,服用 OCP 的女性为 79 ng/dL。与 DST 后游离皮质醇相比,DST 后总皮质醇的诊断准确性为 87.3%(95%CI,81.7-91.7);所有假阳性结果均发生在 DST 后皮质醇在 1.8 和 5 mcg/dL 之间的患者中。OCP 使用是唯一与假阳性结果相关的因素(21.1%比 4.9%,P=0.02)。

结论

在最佳地塞米松浓度和 DST 后皮质醇在 1.8 和 5 mcg/dL 之间的患者中,DST 后游离皮质醇测量值具有重要价值。

相似文献

1
Interpretation of Abnormal Dexamethasone Suppression Test is Enhanced With Use of Synchronous Free Cortisol Assessment.
J Clin Endocrinol Metab. 2022 Feb 17;107(3):e1221-e1230. doi: 10.1210/clinem/dgab724.
3
Simultaneous assay of cortisol and dexamethasone improved diagnostic accuracy of the dexamethasone suppression test.
Eur J Endocrinol. 2017 Jun;176(6):705-713. doi: 10.1530/EJE-17-0078. Epub 2017 Mar 15.
4
Saliva versus serum cortisol to identify subclinical hypercortisolism in adrenal incidentalomas: simplicity versus accuracy.
J Endocrinol Invest. 2019 Dec;42(12):1435-1442. doi: 10.1007/s40618-019-01104-8. Epub 2019 Aug 27.
5
Early assessment of postoperative adrenal function is necessary after adrenalectomy for mild autonomous cortisol secretion.
Surgery. 2021 Jan;169(1):150-154. doi: 10.1016/j.surg.2020.05.046. Epub 2020 Jul 18.
6
Dexamethasone measurement during low-dose suppression test for suspected hypercortisolism: threshold development with and validation.
J Endocrinol Invest. 2020 Aug;43(8):1105-1113. doi: 10.1007/s40618-020-01197-6. Epub 2020 Feb 14.
7
Two-day low-dose dexamethasone suppression test more accurate than overnight 1-mg in women taking oral contraceptives.
Endocrinol Diabetes Metab. 2021 May 26;4(3):e00255. doi: 10.1002/edm2.255. eCollection 2021 Jul.
9
Low DHEAS: A Sensitive and Specific Test for the Detection of Subclinical Hypercortisolism in Adrenal Incidentalomas.
J Clin Endocrinol Metab. 2017 Mar 1;102(3):786-792. doi: 10.1210/jc.2016-2718.

引用本文的文献

1
Dehydroepiandrosterone Sulfate in Diagnosing Mild Autonomous Cortisol Secretion and Adrenal Insufficiency.
J Endocr Soc. 2025 Aug 20;9(9):bvaf136. doi: 10.1210/jendso/bvaf136. eCollection 2025 Sep.
3
Osilodrostat Treatment for Adrenal and Ectopic Cushing Syndrome: Integration of Clinical Studies With Case Presentations.
J Endocr Soc. 2025 Feb 14;9(4):bvaf027. doi: 10.1210/jendso/bvaf027. eCollection 2025 Mar 3.
6
Mild autonomous cortisol secretion: pathophysiology, comorbidities and management approaches.
Nat Rev Endocrinol. 2024 Aug;20(8):460-473. doi: 10.1038/s41574-024-00984-y. Epub 2024 Apr 22.
7
Overnight 1-mg DST Serum Cortisol in Various Stages of Chronic Kidney Disease-Normative Data and Underlying Mechanisms.
J Endocr Soc. 2024 Jan 12;8(3):bvae002. doi: 10.1210/jendso/bvae002. eCollection 2024 Jan 16.
8
Kidney Function in Patients With Adrenal Adenomas: A Single-Center Retrospective Cohort Study.
J Clin Endocrinol Metab. 2024 Aug 13;109(9):e1750-e1758. doi: 10.1210/clinem/dgad765.
9
Relationship Between Overnight Dexamethasone Suppression Test and Aging.
Cureus. 2023 Nov 6;15(11):e48383. doi: 10.7759/cureus.48383. eCollection 2023 Nov.
10
Four-Compartment Diffusion Model of Cortisol Disposition: Comparison With 3 Alternative Models in Current Clinical Use.
J Endocr Soc. 2022 Nov 14;7(2):bvac173. doi: 10.1210/jendso/bvac173. eCollection 2022 Dec 15.

本文引用的文献

1
Decreased maximal cortisol secretion rate in patients with cirrhosis: Relation to disease severity.
JHEP Rep. 2021 Mar 19;3(3):100277. doi: 10.1016/j.jhepr.2021.100277. eCollection 2021 Jun.
3
Risk of bone fractures after the diagnosis of adrenal adenomas: a population-based cohort study.
Eur J Endocrinol. 2021 Apr;184(4):597-606. doi: 10.1530/EJE-20-1396.
5
6
Dexamethasone measurement during low-dose suppression test for suspected hypercortisolism: threshold development with and validation.
J Endocrinol Invest. 2020 Aug;43(8):1105-1113. doi: 10.1007/s40618-020-01197-6. Epub 2020 Feb 14.
7
Retrospective analysis of repeated dexamethasone suppression tests - the added value of measuring dexamethasone.
Ann Clin Biochem. 2019 Nov;56(6):708-710. doi: 10.1177/0004563219870834. Epub 2019 Aug 14.
9
Evaluation of bone health in patients with adrenal tumors.
Curr Opin Endocrinol Diabetes Obes. 2019 Jun;26(3):125-132. doi: 10.1097/MED.0000000000000478.
10
THE EVALUATION OF INCIDENTALLY DISCOVERED ADRENAL MASSES.
Endocr Pract. 2019 Feb;25(2):178-192. doi: 10.4158/DSCR-2018-0565.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验